Deciphera Pharmaceuticals (DCPH) Competitor Comparison
We are evaluating the key criteria listed to compare Deciphera Pharmaceuticals (DCPH) against its competitors in the Biotechnology industry.
Market Capitalization
106 / 368Gross Profits
209 / 278Total Revenue
74 / 300EBITDA
286 / 337Free Cashflow
271 / 352Quick Ratio
222 / 357Earnings per Share
220 / 359Dividend yield
0 / 6Total Cash
95 / 358Performance 3 years
122 / 368Performance 5 years
121 / 368Performance 10 years
91 / 368Linearity 3 years
77 / 368Linearity 5 years
22 / 368Linearity 10 years
36 / 368Total Rank
105 / 368Dividend Rank
106 / 368Valuation Rank
43 / 368Piotroski Rank
66 / 368Muliplier Rank
327 / 368Performance 10 years - DCPH ranking 91 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.